In this presentation, Anand A. Patel, MD, reviewed the contemporary standard-of-care treatment roadmap for AML in 2025, covering key phases like induction chemotherapy (eg, the “7+3” regimen), consolidation…
Eunice S. Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, New York, discusses the treatment strategies for patients who develop secondary acute myeloid leukemia (AML) following hypomethylating agent…
NEW YORK (Reuters Health) – Epoetin alpha can reduce the number of erythrocyte transfusions needed in patients with acute leukemia undergoing myelosuppressive chemotherapy, without affecting length of remission,…
NEW YORK (Reuters Health) – A new study suggests that, in a real-world setting, adjuvant chemotherapy in adults over age 65 with stage II colon cancer and high-risk…
NEW YORK (Reuters Health) – No chemotherapy sensitivity and resistance assays have sufficient supporting evidence to justify their use in oncology practice. That’s the conclusion of an American…
NEW YORK (Reuters Health) – In women undergoing breast-conserving therapy for early breast cancer, the presence of occult metastasis not seen with routine pathological examination in sentinel lymph…
NEW YORK (Reuters Health) – In young women with breast cancer, temporary ovarian suppression by the gonadotropin-releasing hormone analogue triptorelin during chemotherapy reduces the occurrence of premature menopause,…
NEW YORK (Reuters Health) – In postmenopausal women with node-positive early breast cancer, substituting docetaxel for epirubicin for the last three cycles of chemotherapy may improve outcome without…
NEW YORK (Reuters Health) – An investigational agent, ARC1779, reduces cerebral emboli resulting from carotid endarterectomy by inhibiting the prothrombotic effects of von Willebrand factor (vWF), according to…
NEW YORK (Reuters Health) – When used as adjuvant therapy in high-risk breast cancer or as primary treatment for metastatic breast cancer, high-dose chemotherapy (HDC) with autologous stem-cell…
NEW YORK (Reuters Health) – In select patients with American Joint Committee on Cancer (AJCC) stage II colon cancer, adjuvant chemotherapy after resection improves survival, according to a…
NEW YORK (Reuters Health) – In patients with atrial fibrillation (AF), combination antithrombotic therapy with an anticoagulant and an antiplatelet increases the risk for clinically relevant bleeding with…
